News Article

Rising drug prices an ongoing issue, Ascension leader says

Rising drug prices an ongoing issue, Ascension leader says

Rising pharmaceutical costs are among the most urgent and unsustainable issues hospital supply chain leaders face, according to Scott Caldwell, President and CEO of The Resource Group, Ascension’s group purchasing organization.

Scott recently spoke with Becker’s Hospital Review about the key healthcare supply chain challenges.

“We continue to see aggressive and unwarranted price increases for drugs that are critical to care for patients and where substitutes are not available,” he said. “For hospital supply chain leaders, this paradigm is not only pressing, it is unsustainable.”

Scott said Ascension has been able to mitigate rising costs through the use of e-auctions to increase competition and transparency; a pharmaceutical inventory management system and processes; clinically appropriate auto-substitution programs; and antimicrobial stewardship programs.

He also noted how the supply chain model is built on the concepts of high-quality customer service, hospitality and listening. “Everything we do is with these concepts in mind, and this is where the industry needs to go,” he said.

Click here for the story.

Recent National News
Quarterly transformation update: Care closer to home, designed around people, built to last
News Articles

Quarterly transformation update: Care closer to home, designed around people, built to last

Across our markets, new and refreshed care environments are being designed to feel more welcoming, intuitive, and responsive, helping reduce stress and support healing from the moment patients arrive.
Culture: The Most Enduring Competitive Advantage
News Articles

Culture: The Most Enduring Competitive Advantage

By any rational measure, competitive advantage has never been more fleeting.
Ascension awarded funding to implement improved hypertension management
News Articles

Ascension awarded funding to implement improved hypertension management

Ascension has been awarded funding by the Patient-Centered Outcomes Research Institute (PCORI) to implement an improved evidence-based approach to hypertension management.